跳至主要内容
临床试验/ITMCTR2000003021
ITMCTR2000003021尚未招募未知

Traditional Chinese medicine cooperative therapy for patients with Bladder Cancer after operation: a randomized controlled trial

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
25 至 80(—)
性别
Male

入选标准

  • 1. In line with transurethral resection of bladder tumor (TURPBT), and pathological diagnosis of malignant tumors;
  • 2. The Karnofsky Performance Status (KPS) score >60 points, and the expected survival period >1 year;
  • 3. Aged 25 to 80 years;
  • 4. Those who have voluntarily signed an informed consent form.

排除标准

  • 1. Allergic constitution and those who are allergic to experimental drugs;
  • 2. Patients with renal cancer, bladder tuberculosis, and urinary calculi;
  • 3. Combined with other malignant tumor patients;
  • 4. Patients with blood system diseases, coagulopathy and autoimmune diseases;
  • 5. Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients;
  • 6. Participated in other clinical researchers 3 months before the trial;
  • 7. Non-resection of bladder tumors.

研究者

发起方
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

相似试验

Traditional Chinese medicine cooperative therapy for... | 临床试验